Chen, B., Zheng, D., Yu, W., Huang, C., Ye, J., Han, G., & Zhuang, J. (2020). Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer. J Int Med Res.

Chen, Baomin, Donghua Zheng, Weiguang Yu, Cuiping Huang, Junxing Ye, Guowei Han, ja Jintao Zhuang. "Cetuximab Versus Bevacizumab Maintenance Following Prior 8-cycle Modified FOLFOXIRI Plus Cetuximab in Asian Postmenopausal Women With Treatment-naive KRAS and BRAF Wild-type Metastatic Colorectal Cancer." J Int Med Res 2020.

Chen, Baomin, et al. "Cetuximab Versus Bevacizumab Maintenance Following Prior 8-cycle Modified FOLFOXIRI Plus Cetuximab in Asian Postmenopausal Women With Treatment-naive KRAS and BRAF Wild-type Metastatic Colorectal Cancer." J Int Med Res 2020.